Bajaj Healthcare grants 275 ESOPs at ₹5 per option

1 min read     Updated on 20 Jul 2026, 11:04 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Bajaj Healthcare's Nomination & Remuneration Committee approved the grant of 275 stock options to an eligible employee under its 2024 plan. The options, priced at ₹5 each, are convertible into one fully paid-up equity share with a face value of ₹5. The scheme complies with SEBI (SBEB) Regulations, 2021.

powered bylight_fuzz_icon
46114458

*this image is generated using AI for illustrative purposes only.

Bajaj Healthcare Limited granted 275 stock options to an eligible employee under its Bajaj Healthcare Limited Employee Stock Option Plan 2024. The Nomination & Remuneration Committee approved the grant at an exercise price of ₹5 per option on July 20, 2026. Each option is convertible into one fully paid-up equity share with a face value of ₹5, covering a total of 275 equity shares.

The scheme is in terms of the SEBI (SBEB) Regulations, 2021. Options vest over a maximum period of four years from the date of grant, with a minimum period of one year between the grant and vesting. Vested options may be exercised by the grantee within five years from the date of vesting.

Grant Details

Particulars Details
Options Granted 275
Exercise Price ₹5 per option
Face Value ₹5 per share
Vesting Period Maximum 4 years
Exercise Period 5 years from vesting

Eligibility for participation includes employees working in India or abroad, and directors who are not promoters or independent directors. The scheme excludes employees who are promoters or belong to the promoter group, as well as independent directors. Shares arising from the exercise of options are not subject to a lock-in period, though trading restrictions under the company's insider trading code apply.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Bajaj HealthCare

1 Day5 Days1 Month6 Months1 Year5 Years
+2.75%+5.90%-4.27%-2.77%-32.44%-7.30%

How will the company fund potential future ESOP grants if the current pilot is successful?

What impact will the vesting schedule have on employee retention rates over the next four years?

Could the exercise price of ₹5 signal management's confidence in the company's future stock performance?

Bajaj Healthcare to discuss Q1FY27 results on July 21

0 min read     Updated on 17 Jul 2026, 04:15 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Bajaj Healthcare announced an earnings call for July 21, 2026, at 4:00 PM IST to discuss Q1FY27 financial results under Regulation 30 of SEBI (LODR) Regulations, 2015. Managing Director Anil Jain and CFO Rohan Parekh will represent the company. Stakeholders can access the call via universal or international dial-in numbers.

powered bylight_fuzz_icon
45772043

*this image is generated using AI for illustrative purposes only.

Bajaj Healthcare has scheduled an earnings call to discuss its financial performance for the quarter ended June 30, 2026. The conference is set for July 21, 2026, at 4:00 PM IST, providing stakeholders a platform to review the company's Q1FY27 results.

Earnings Call Details

The announcement was made under Regulation 30 of the SEBI (LODR) Regulations, 2015. Managing Director Anil Jain and Chief Financial Officer Rohan Parekh will represent the company during the session.

Parameter Details
Event Q1FY27 Earnings Call
Date July 21, 2026
Time 4:00 PM IST
Representatives Anil Jain (MD), Rohan Parekh (CFO)

Conference Access

Participants can join the discussion via universal dial-in numbers or international toll-free lines. Pre-registration is recommended to avoid wait time.

Universal Dial In: +91 22 6280 1550 / +91 22 7115 8378

International Toll Free:

  • Hong Kong: 800964448
  • Singapore: 8001012045
  • UK: 08081011573
  • USA: 18667462133

Stakeholders may direct RSVP queries to Mr. Rohan Parekh at investors@bajajhealth.com .

Historical Stock Returns for Bajaj HealthCare

1 Day5 Days1 Month6 Months1 Year5 Years
+2.75%+5.90%-4.27%-2.77%-32.44%-7.30%

What strategic initiatives is Bajaj Healthcare pursuing to drive growth in FY27?

How are recent regulatory changes impacting the company's operational margins?

What are the key market trends expected to influence the healthcare sector in the coming quarters?

More News on Bajaj HealthCare

Must Read Next

Corporate Actions

Prism Johnson Acquires Additional 8.5% Stake in Samini Ceramics for ₹15.31 Crore, Total Holding Rises to 98.5% 11 hrs ago
ZEE Entertainment Shareholders Greenlight Warrant Issuance to Promoter Group on Preferential Terms 11 hrs ago
ABB India Declares Special Dividend of ₹90 Per Share 14 hrs ago
no imag found
1 Year Returns:-32.44%